Tenet Common Stock vs Net Receivables Analysis
THC Stock | USD 143.63 4.29 2.90% |
Tenet Healthcare financial indicator trend analysis is much more than just breaking down Tenet Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tenet Healthcare is a good investment. Please check the relationship between Tenet Healthcare Common Stock and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.
Common Stock vs Net Receivables
Common Stock vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tenet Healthcare Common Stock account and Net Receivables. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Tenet Healthcare's Common Stock and Net Receivables is -0.52. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Tenet Healthcare, assuming nothing else is changed. The correlation between historical values of Tenet Healthcare's Common Stock and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Tenet Healthcare are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock i.e., Tenet Healthcare's Common Stock and Net Receivables go up and down completely randomly.
Correlation Coefficient | -0.52 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Common Stock
Net Receivables
Most indicators from Tenet Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tenet Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.At present, Tenet Healthcare's Enterprise Value Over EBITDA is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 6.67, whereas Selling General Administrative is forecasted to decline to about 6.8 B.
2021 | 2022 | 2024 (projected) | Interest Expense | 923M | 890M | 752.6M | Depreciation And Amortization | 855M | 841M | 524.6M |
Tenet Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Tenet Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tenet Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 23.4B | 27.1B | 27.6B | 27.2B | 28.3B | 29.7B | |
Short Long Term Debt Total | 14.8B | 15.7B | 15.6B | 15.1B | 16.2B | 17.0B | |
Other Current Liab | 1.4B | 3.0B | 2.7B | 2.7B | 3.0B | 3.2B | |
Total Current Liabilities | 4.2B | 4.8B | 5.1B | 4.5B | 4.8B | 2.5B | |
Total Stockholder Equity | (371M) | 28M | 1.0B | 1.1B | 1.6B | 1.3B | |
Property Plant And Equipment Net | 6.9B | 6.7B | 6.4B | 6.5B | 7.3B | 5.4B | |
Net Debt | 14.5B | 13.3B | 13.3B | 14.2B | 15.0B | 15.7B | |
Retained Earnings | (2.5B) | (2.1B) | (1.2B) | (803M) | (192M) | (201.6M) | |
Cash | 262M | 2.4B | 2.4B | 858M | 1.2B | 1.3B | |
Non Current Assets Total | 18.3B | 20.0B | 20.5B | 21.2B | 21.1B | 22.2B | |
Non Currrent Assets Other | 308M | 315M | 317M | 389M | 180M | 214.4M | |
Cash And Short Term Investments | 262M | 2.4B | 2.4B | 858M | 1.2B | 1.3B | |
Net Receivables | 2.8B | 3.4B | 3.3B | 3.5B | 4.0B | 4.2B | |
Common Stock Shares Outstanding | 103.4M | 106.3M | 108.6M | 110.5M | 104.8M | 108.2M | |
Liabilities And Stockholders Equity | 23.4B | 27.1B | 27.6B | 27.2B | 28.3B | 29.7B | |
Non Current Liabilities Total | 17.2B | 19.4B | 18.2B | 18.1B | 18.0B | 18.9B | |
Inventory | 310M | 368M | 384M | 405M | 411M | 211.5M | |
Other Current Assets | 1.4B | 1.4B | 1.0B | 1.3B | 1.5B | 1.6B | |
Other Stockholder Equity | 2.3B | 2.4B | 2.5B | 2.1B | 2.0B | 2.6B | |
Total Liab | 21.4B | 24.2B | 23.3B | 22.5B | 22.8B | 23.9B | |
Property Plant And Equipment Gross | 8.0B | 7.9B | 13.5B | 13.8B | 13.8B | 14.5B | |
Total Current Assets | 5.1B | 7.1B | 7.1B | 6.0B | 7.2B | 7.5B | |
Accumulated Other Comprehensive Income | (257M) | (281M) | (233M) | (181M) | (208.2M) | (218.6M) | |
Short Term Debt | 171M | 333M | 135M | 145M | 324M | 340.2M | |
Intangible Assets | 1.6B | 1.6B | 1.5B | 1.4B | 1.4B | 1.3B | |
Other Liab | 1.7B | 3.8B | 2.7B | 2.1B | 2.4B | 1.7B | |
Other Assets | 646M | 325M | 65M | 19M | 21.9M | 20.8M | |
Long Term Debt | 14.6B | 15.6B | 15.5B | 14.9B | 14.9B | 9.6B | |
Good Will | 7.3B | 8.8B | 9.3B | 10.1B | 10.3B | 10.8B | |
Property Plant Equipment | 7.8B | 6.7B | 6.4B | 6.5B | 7.4B | 6.6B | |
Current Deferred Revenue | 1.5B | 659M | 959M | 110M | 59M | 56.1M | |
Net Tangible Assets | (7.7B) | (8.4B) | (9.7B) | (8.3B) | (7.4B) | (7.8B) | |
Noncontrolling Interest In Consolidated Entity | 854M | 909M | 1.0B | 1.3B | 1.5B | 1.6B | |
Retained Earnings Total Equity | (2.5B) | (2.1B) | (1.2B) | (803M) | (722.7M) | (758.8M) | |
Long Term Debt Total | 14.6B | 15.6B | 15.5B | 14.9B | 17.2B | 13.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.215 | Earnings Share 31.57 | Revenue Per Share 213.204 | Quarterly Revenue Growth 0.011 | Return On Assets 0.0699 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.